While others battle sudden vomiting, bloating, diarrhea, or painful constipation, these symptoms usually peak during the increase in dose
GLP-1 Drugs: The Strongest Path to Lasting Weight Loss & Improvement in Related Health Conditions September 12, 2025 By: Janet Klein, MS, RDN, CDN, CDCES Categories: Bariatric, Blog, Health & Wellness Janet Klein, MS RDN, CDN, CDCES, Bariatric Surgery and Obesity Medicine Program Director It may not be much of a surprise to hear that with the increased use of GLP-1s for weight loss, there has been a noted decline in patients undergoing bariatric surgery
However, a significant reduction in left atrial volume [mean difference 8.7 mL ( 14.2, 3.2), P = 0.002] and in E/e ratio [mean difference 1.4 ( 2.7, 0.1), P = 0.03] [52] was reported
doi: 10.1002/jbm4.10209 61 MaXMengJJiaMBiLZhouYWangYet al